- Home
- SWTX vs AVAL Comparison
SWTX vs AVAL Comparison
Compare SWTX & AVAL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SWTX
- AVAL
- Stock Information
- Founded
- SWTX 2017
- AVAL 1994
- Country
- SWTX United States
- AVAL Colombia
- Employees
- SWTX N/A
- AVAL N/A
- Industry
- SWTX Biotechnology: Pharmaceutical Preparations
- AVAL Commercial Banks
- Sector
- SWTX Health Care
- AVAL Finance
- Exchange
- SWTX Nasdaq
- AVAL Nasdaq
- Market Cap
- SWTX 3.0B
- AVAL 2.4B
- IPO Year
- SWTX 2019
- AVAL N/A
- Fundamental
- Price
- SWTX $47.41
- AVAL $2.70
- Analyst Decision
- SWTX Strong Buy
- AVAL
- Analyst Count
- SWTX 5
- AVAL 0
- Target Price
- SWTX $72.40
- AVAL N/A
- AVG Volume (30 Days)
- SWTX 2.0M
- AVAL 125.8K
- Earning Date
- SWTX 05-01-2025
- AVAL 05-15-2025
- Dividend Yield
- SWTX N/A
- AVAL 4.50%
- EPS Growth
- SWTX N/A
- AVAL 37.36
- EPS
- SWTX N/A
- AVAL 0.01
- Revenue
- SWTX $191,589,000.00
- AVAL $2,661,902,702.00
- Revenue This Year
- SWTX $85.98
- AVAL $58.02
- Revenue Next Year
- SWTX $69.16
- AVAL $9.86
- P/E Ratio
- SWTX N/A
- AVAL $13.99
- Revenue Growth
- SWTX 3417.33
- AVAL 0.20
- 52 Week Low
- SWTX $28.21
- AVAL $1.94
- 52 Week High
- SWTX $62.00
- AVAL $3.32
- Technical
- Relative Strength Index (RSI)
- SWTX 44.48
- AVAL 42.50
- Support Level
- SWTX $45.88
- AVAL $2.70
- Resistance Level
- SWTX $51.43
- AVAL $2.82
- Average True Range (ATR)
- SWTX 2.12
- AVAL 0.12
- MACD
- SWTX -0.66
- AVAL -0.03
- Stochastic Oscillator
- SWTX 23.47
- AVAL 10.81
About SWTX SpringWorks Therapeutics Inc.
SpringWorks Therapeutics Inc is a clinical stage biopharmaceutical company applying a precision medicine approach to acquiring, developing and commercializing life-changing medicines for underserved patient populations suffering from devastating rare diseases and cancer. The company has a differentiated portfolio of small molecule targeted oncology product candidates and is advancing two potentially registrational clinical trials in rare tumor types, as well as several other programs addressing highly prevalent, genetically defined cancers.
About AVAL Grupo Aval Acciones y Valores S.A. ADR (Each representing 20 preferred shares)
Grupo Aval Acciones y Valores SA is a Colombian financial services company. Its local operations consist of commercial banking (Banco de Bogota, Banco de Occidente, Banco Popular, and Banco AV Villas), pension fund management (Porvenir), and merchant banking (Corficolombiana). Outside Colombia, the company offers (via BAC Credomatic operations) consumer and credit card banking businesses in Central American countries (Costa Rica, El Salvador, Guatemala, Honduras, Nicaragua, and Panama) and Mexico. BAC Credomatic has key alliances with major credit card networks, such as Visa, MasterCard, American Express, and Diners Club.